PCSK9 and Venous thrombosis: Thus, transgenic PCSK9+/+ murine models showed a systemic hypercoagulable environment reflected by elevated circulating thrombin/antithrombin complexes [30] while PCSK9−/− mice developed less venous thrombosis after inferior vena cava ligation as compared with wild strains [31].